Analytical and Experimental Evaluation of the Heat Transfer Distribution over the Surfaces of Turbine Vanes

Three airfoil data sets were selected for use in evaluating currently available analytical models for predicting airfoil surface heat transfer distributions in a 2-D flow field. Two additional airfoils, representative of highly loaded, low solidity airfoils currently being designed, were selected for cascade testing at simulated engine conditions. Some 2-D analytical methods were examined and a version of the STAN5 boundary layer code was chosen for modification. The final form of the method utilized a time dependent, transonic inviscid cascade code coupled to a modified version of the STAN5 boundary layer code featuring zero order turbulence modeling. The boundary layer code is structured to accommodate a full spectrum of empirical correlations addressing the coupled influences of pressure gradient, airfoil curvature, and free-stream turbulence on airfoil surface heat transfer distribution and boundary layer transitional behavior. Comparison of pedictions made with the model to the data base indicates a significant improvement in predictive capability

Aerosol deposition of lipid complex Amphotericin-B (Abelcet) in lung transplant recipients

Lung transplant recipients exhibit a high incidence of invasive aspergillosis. The inhalation of lipid complex amphotericin-B (Abelcet; ABLC) offers a possible prophylactic strategy. The goals of this study were to select the optimal nebulizer delivery system for ABLC and to measure deposited aerosol dose in 12 lung transplant recipients. In vitro testing was performed to select a nebulizer delivery system, and an empirical model was used to estimate lung deposition. Estimated pulmonary doses varied by as much as 2-fold between different nebulizers. Aerosol deposition testing was performed in six single and six double lung recipients, each of whom received one 7 mL (35 mg) nebulized dose of Technetium-labeled ABLC using the selected nebulizer. In single lung recipients, the average deposited doses were 3.9 ± 1.6 mg (mean ± S.D.)in the allograft versus 2.1 ± 1.1 mg in the native lung. Double lung recipients deposited on average 2.8 ± 0.8 mg (left lung) and 4.0 ± 1.3 mg (right lung). The drug was well distributed throughout the lungs, but delivery to the native lung was in some cases suboptimal. These studies provide an important precursor to studies of the efficacy of inhaled ABLC as a prophylaxis of invasive aspergillosis after lung transplant